Novartis a multinational pharmaceutical company, founded in 1996 with the merger of Ciba-Geigy and Sandoz Laboratories has its headquarters in Basel in Switzerland.
Considered as the world leader in the discovery, development, manufacture and marketing of prescription medicines,
Novartis markets products in therapeutical areas like Cardiovascular & Metabolism, Neuroscience, Respiratory & Dermatology, ABGHI (Arthritis, bone, gastrointestinal, hormone replacement therapies, urinary incontinence), Infectious
diseases, Oncology & Hematology, Transplantation & Immunology and Ophthalmics.
Novartis excels in offering products for the treatment of cardiovascular disease, high blood pressure, elevated cholesterol, chest pain and heart failure. It is also a leader in neuroscience and manufactures products that helps in the treatment of Alzheimer's disease, Parkinson's disease, attention deficit / hyperactivity disorder, epilepsy, depression, migraine and schizophrenia.
Novartis, which offers medicines for respiratory and dermatological conditions, also leads in producing medicines for various internal diseases such as gastrointestinal disorders, urinary incontinence, arthritis, osteoporosis and pain. The production of anti-viral, anti-bacterial and tropical medicine, which are very effective, makes
Novartis an outstanding pharmaceutical company. The company is also known for producing a range of innovative therapies and practical solutions aimed at cancer patients. Its products, which help in the protection of transplanted organs from rejection and also for ophthalmic treatments are very effective.
Address: Lichtstrasse 35, Basel, Switzerland 4056
Phone: 41-61-324-1111
